STOCKHOLM, Sweden & RADNOR, PA – Immedica Pharma AB has announced its plan to acquire Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) in a transaction valued at approximately $151 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback